Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Scrophularia ningpoensis is a perennial herb in the family Scrophulariaceae whose root (known as Xuan Shen or 玄参) has been used in traditional Chinese medicine for over two millennia. The root is traditionally employed for its "heat-clearing," "detoxifying," and yin-nourishing properties. It is commonly used to treat conditions such as inflammation (including sore throat and skin infections), feverish illnesses with rashes or delirium, hypertension, diabetes mellitus symptoms (notably thirst), carbuncles/abscesses and other inflammatory skin disorders. Modern pharmacological studies have identified more than 160 compounds from the root—including iridoid glycosides (e.g., harpagide and harpagoside), phenylpropanoid glycosides (e.g., acteoside/angoroside C), phenolic acids/flavonoids/triterpenes/saponins—many of which exhibit anti-inflammatory, antioxidant/cytoprotective effects on cardiovascular/liver/nervous systems[2][7][9]. The main active constituents are believed to be iridoid glycosides and phenylpropanoid glycosides[2][7]. Mechanistically it may modulate inflammatory pathways but specific molecular targets remain under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on scrophularia ningpoensis.